RT Journal Article SR Electronic T1 The Role of Vitamin D in The Age of COVID-19: A Systematic Review and Meta-Analysis JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.06.05.20123554 DO 10.1101/2020.06.05.20123554 A1 Roya Ghasemian A1 Amir Shamshirian A1 Keyvan Heydari A1 Mohammad Malekan A1 Reza Alizadeh-Navaei A1 Mohammad Ali Ebrahimzadeh A1 Hamed Jafarpour A1 Arash Rezaei Shahmirzadi A1 Mehrdad Khodabandeh A1 Benyamin Seyfari A1 Alireza Motamedzadeh A1 Ehsan Dadgostar A1 Marzieh Aalinezhad A1 Meghdad Sedaghat A1 Morteza Behnamfar A1 Anahita Asadi A1 Bahman Zarandi A1 Nazanin Razzaghi A1 Vahid Yaghoubi Naei A1 Amirhossein Hessami A1 Soheil Azizi A1 Ali Reza Mohseni A1 Danial Shamshirian YR 2020 UL http://medrxiv.org/content/early/2020/10/26/2020.06.05.20123554.abstract AB Background Evidence recommends that vitamin D might be a crucial supportive agent for the immune system, mainly in cytokine response regulation against COVID-19. Hence, we carried out a systematic review and meta-analysis in order to maximize the use of everything that exists about the role of vitamin D in the COVID-19.Methods A systematic search was performed in PubMed, Scopus, Embase, Cochrane Library, Web of Science, and Google Scholar (intitle) as well as preprint database of medRxiv, bioRxiv, Research Square, preprints.org, and search engine of ScienceDirect up to October 10, 2020. Studies focused on the role of vitamin D in confirmed COVID-19 patients were entered into the systematic review.Results Sixteen studies containing 4922 participants entered into the meta-analysis. The meta-analysis indicated that 48% of COVID-19 patients were suffering from vitamin D deficiency (95% CI, 29%-67%), and in 41% of patients, levels of vitamin D were insufficient (95% CI, 10%-82%). The serum 25-hydroxyvitamin D concentration was 18 ng/mL among all COVID-19 patients (95% CI, 13-24). Co-morbidities frequency in COVID-19 patients were as follows: 7.4% cancer, 27.1% chronic kidney disease, 30.4% cardiovascular diseases, 5.1% dementia, 14.5% depression/anxiety, 32.1% diabetes, 47.4% hypertension, 22.0% obesity and 17.5% respiratory diseases. Reported ethnic groups in studies were 1.0% Afro-Caribbean, 10.3% Asian, and 92.1% Caucasian.Conclusion This study found that the mean serum 25-hydroxyvitamin D level was low in all COVID-19 patients, and most of them were suffering from vitamin D deficiency/insufficiency. The Caucasian was the dominant ethnic group, and the most frequent co-morbidities in COVID-19 patients were hypertension, cardiovascular diseases, chronic kidney disease, diabetes, obesity, and respiratory diseases, which might be affected by vitamin D deficiency directly or indirectly.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A